The AI shift is real: How pharmaceutical leaders are operationalizing AI
· Source: microsoft.com
In short
Pharmaceutical companies are moving AI from experimentation into core scientific, manufacturing, operational, and commercial workflows, driven by pressure to accelerate R&D, strengthen supply chain resilience, and cut costs. Microsoft highlights examples such as Novo Nordisk, Amgen, Körber, Rohto Pharmaceutical, and Pierre Fabre, which report faster insights, reduced manual work, and improved operational accuracy. The article argues that lasting advantage depends on data readiness, governance, and redesigning workflows rather than merely adopting AI technology.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 38, 2026: AI Moves Closer to Supply Chain Decisions, but Data and Returns Still Lag
Tags: pharma, supply chain, manufacturing, automation, agents, resilience